pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›MEDROL
drug · small molecule
save

MEDROL

Marketedupdated 3mo ago
by $PFE PFIZER INC🔗 ChEMBL
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval454 co-mentions · 127 sources
  • drugMETHYLPREDNISOLONE231 co-mentions · 131 sources
  • drugSOLU-MEDROL192 co-mentions · 48 sources
  • drugDEPO-MEDROL137 co-mentions · 44 sources
  • drugmethylprednisolone sodium succinate96 co-mentions · 48 sources
  • drugMETHYLPREDNISOLONE ACETATE75 co-mentions · 44 sources
  • tagSmall Molecule58 co-mentions · 37 sources
  • companyGreenstone LLC2 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 17 approved and 94 investigational indications.

indications

investigational
IBD (Crohn's + UC)Rheumatoid ArthritisPsoriasisLupusAsthma

targets

Glucocorticoid receptor

all catalysts(34)

approval · 33
Oct 24, 1957
approval
$PFE28.24+3.63%
69y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Sep 10, 1976
approval
$PFE28.24+3.63%
50y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Apr 11, 1978
approval
$PFE28.24+3.63%
48y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Apr 5, 1979
approval
$PFE28.24+3.63%
47y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Apr 5, 1979
approval
$PFE28.24+3.63%
47y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
May 30, 1979
approval
$PFE28.24+3.63%
47y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Apr 14, 1980
approval
$PFE28.24+3.63%
46y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Oct 8, 1980
approval
$PFE28.24+3.63%
46y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Mar 9, 1983
approval
$PFE28.24+3.63%
43y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Feb 24, 1987
approval
$PFE28.24+3.63%
40y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Jan 5, 1989
approval
$PFE28.24+3.63%
38y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Jan 28, 1993
approval
$PFE28.24+3.63%
34y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Dec 28, 1993
approval
$PFE28.24+3.63%
33y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Oct 31, 1997
approval
29y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Dec 5, 1997
approval
29y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Jun 23, 1998
approval
28y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Oct 29, 1999
approval
27y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Dec 1, 1999
approval
$PFE28.24+3.63%
27y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Oct 12, 2001
approval
25y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Oct 12, 2001
approval
25y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Oct 25, 2002
approval
$PFE28.24+3.63%
24y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Nov 20, 2002
approval
24y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Nov 20, 2002
approval
24y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Jul 18, 2013
approval
$PFE28.24+3.63%
13y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Jul 24, 2018
approval
$PFE28.24+3.63%
8y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Aug 26, 2019
approval
$PFE28.24+3.63%
7y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Dec 19, 2023
approval
$PFE28.24+3.63%
3y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Jun 5, 2024
approval
$PFE28.24+3.63%
2y ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Aug 1, 2025
approval
1y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Aug 1, 2025
approval
1y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Aug 1, 2025
approval
1y ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
Nov 4, 2025
approval
$PFE28.24+3.63%
10mo ago
MEDROL (METHYLPREDNISOLONE) — FDA approval
MEDROL
→
Apr 10, 2026
approval
4mo ago
METHYLPREDNISOLONE — FDA approval
MEDROL
→
phase 0 trial completion · 1
Apr 30, 2026
phase 0 trial completion
4mo ago
University of Southern California — methylprednisolone (Phase 0 Trial Completion)
MEDROL
→
view all 34 catalysts →

Trials studying MEDROL

  • phase2Lazarus: IT Therapy for ICANSnot yet recruitingn=59
  • phase4A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Diseaserecruitingn=92
  • phase3A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)recruitingn=1,046
  • phase3A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritisactive not recruitingn=271
  • phase3Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritisnot yet recruitingn=240
  • phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participantsrecruitingn=40
  • phase3Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Researchrecruitingn=210
  • phase3A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantationrecruitingn=526
more trials →

News(1)

  • Opinion: The U.S. pharmaceutical supply chain problem is not about China
    The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.
    stat · 26d ago
brand
MEDROL
trade names
Medrol, Medrone, Methylprednisolone, Methylprednisolone component of neo-medrol
generic
METHYLPREDNISOLONE
MOA
Glucocorticoid receptor agonist
phase
marketed
Data sources
openFDA · ClinicalTrials.gov · OpenTargets
last refreshed 36m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?